Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2026
  • Page 16
bone-marrow-immune-cell-map-boosts-survival,-relapse-prediction-in-multiple-myeloma
Posted inGenetics

Bone Marrow Immune Cell Map Boosts Survival, Relapse Prediction in Multiple Myeloma

January 9, 2026
A map of the immune cell landscape found in the bone marrow of patients with multiple myeloma could shed light…
Read More
new-single‑cell-testing-measures-how-effectively-antibiotics-kill-bacteria
Posted inGenetics

New Single‑Cell Testing Measures How Effectively Antibiotics Kill Bacteria

January 9, 2026
Biofilm of antibiotic resistant bacteria. Rod-shaped and spherical bacteria. E. coli, Pseudomonas, Mycobacterium tuberculosis, Klebsiella, Staphylococcus aureus, MRSA. 3D illustration…
Read More
airnexis-takes-flight-with-$200m,-links-up-with-china-pharma-for-copd-asset-in-$955m-biobucks-deal
Posted inBiotechnology

AirNexis takes flight with $200M, links up with China pharma for COPD asset in $955M biobucks deal

January 9, 2026
AirNexis Therapeutics is taking flight with $200 million and a clinical-stage asset from a Chinese pharma that aims to treat…
Read More
comparing-whole-genome-sequencing-methods-for-capripox-viruses
Posted inBiotechnology

Comparing Whole Genome Sequencing Methods for Capripox Viruses

January 9, 2026
Title: Advancements in Whole Genome Sequencing Approaches for Capripox Viruses In the realm of virology, Capripox viruses have garnered increasing…
Read More
madrigal-pays-$50m-for-pfizer-mash-drug-with-eye-on-rezdiffra-combo-potential
Posted inBiotechnology

Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential

January 9, 2026
Madrigal has paid Pfizer $50 million for the rights to a DGAT2i inhibitor with the intention of combining the drug…
Read More
quanterix-nabs-illumina’s-cco-as-new-leader,-but-leerink-warns-of-‘significant-lift’-needed-for-turnaround
Posted inMedical Technology

Quanterix nabs Illumina’s CCO as new leader, but Leerink warns of ‘significant lift’ needed for turnaround

January 9, 2026
Quanterix has a new chief executive and president in Everett Cunningham, but analysts at Leerink see Illumina’s former commercial chief…
Read More
baby-kj-scientist-launches-personalized-crispr-therapy-startup
Posted inBiotechnology

Baby KJ scientist launches personalized CRISPR therapy startup

January 9, 2026
Menlo Ventures has made a $16 million bet that the “baby KJ” custom CRISPR therapy success story is repeatable. The…
Read More
r-loops-drive-rnapii-reprogramming-in-early-development
Posted inBiotechnology

R-Loops Drive RNAPII Reprogramming in Early Development

January 9, 2026
In a groundbreaking study poised to reshape our understanding of early mammalian development, researchers have uncovered a pivotal role for…
Read More
youth-sarcopenia-and-body-composition-via-bioimpedance
Posted inBiotechnology

Youth Sarcopenia and Body Composition via Bioimpedance

January 9, 2026
In a groundbreaking advancement in pediatric health assessment, researchers have unveiled comprehensive bioelectrical impedance analysis (BIA) reference values tailored specifically…
Read More
circrna14781-drives-olaparib-resistance-in-ovarian-cancer
Posted inBiotechnology

CircRNA14781 Drives Olaparib Resistance in Ovarian Cancer

January 9, 2026
In a groundbreaking study, researchers have uncovered the role of a specific circular RNA, CircRNA14781, in contributing to olaparib resistance…
Read More

Posts pagination

Previous page 1 … 14 15 16 17 18 … 62 Next page

Privacy Policy    Terms

Scroll to Top